LLY

Company overview unavailable

$1,183.46

+$1.57 (+0.13%)

Last close · 2026-09-25

Free AI rating for LLY

See QuantAdvisor's buy/sell/hold call and the reasoning — no account needed.

Price history

Daily closing prices for LLY.

-$46.47 (-3.78%) over the last 3m

Related news

Recent coverage of LLY.

Innovation Is Driving a New Bull Market in Biotech. 16 Ways to Play It, From Our Roundtable Experts.

Biotechnology stocks are soaring this year as medical advances and merger activity rekindle investor interest. More gains lie ahead, our healthcare panel says.

Yahoo · 5h ago

Foundayo’s Early Growth Is Raising Lilly (LLY)’s Revenue Expectations. But Can It Outrun Pricing Pressure?

Eli Lilly and Company (NYSE:LLY) received a modest price target raise on September 18 from Guggenheim. The brokerage increased its target to $1,284 from $1,273 while maintaining a Buy rating on the pharma stock. But perhaps the more important change was in Foundayo estimates. Guggenheim sharply raised its revenue forecasts for Lilly’s oral obesity drug, […]

Yahoo · 22h ago

Here's Where Wall Street Analysts See Eli Lilly's Share Price Going

Eli Lilly's share price climb has decelerated in 2026.

Yahoo · 1d ago

Lilly Cut an Obesity Drug -- but the Move Shows How High Its Bar Has Become

Eli Lilly is the leader in the GLP-1 space, but not every new drug the company is working on will be a winner.

Yahoo · 1d ago

'We Don't Know What the Risks Are': GLP-1 Pill Boom Fuels Hundreds of Apps, but Research Is Lagging

Oral GLP-1 weight-loss pills are driving a health-tech boom, but research on their safe use is struggling to keep pace.

Benzinga · 1d ago

A Jury Awarded Nektar $90 Million From Eli Lilly. Here’s Why the Stock Barely Moved

Key Stats for Eli Lilly StockCurrent Price: $1,183. 46Target Price (Mid): ~$2,060Street Target: ~$1,325Potential Total Return: ~74%Annualized IRR: ~14% / yearWhat Happened?Eli Lilly and Company (LLY) closed essentially flat at $1,183.

Yahoo · 1d ago

MarketBeat Week in Review – 09/21 - 09/25

A weekly roundup of MarketBeat analysis on volatile markets, oil, bond rates, AI stocks, dividend picks, and earnings outlooks, covering companies from NVIDIA to Tesla and Qualcomm.

Yahoo · 1d ago

Eli Lilly (LLY) vs. Novo Nordisk (NVO): Has the GLP-1 Race Changed the Moat?

Eli Lilly and Company (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) were once viewed as the two big winners of the GLP-1 boom. However, the market’s view of the two companies has changed sharply. Since mid-2024, Novo’s stock has fallen roughly 74%, while Lilly’s has gained about 35%. That difference is also reflected in their valuations, […]

Yahoo · 1d ago

Key statistics

Company fundamentals are temporarily unavailable.

StockTwits chatter

What traders are saying on StockTwits right now

No StockTwits chatter available right now.

Source: StockTwits

Community